NCT03127449 2025-04-03AST2818 in Advanced Non-Small Cell Lung Cancer With EGFR MutationsAllist Pharmaceuticals, Inc.Phase NA Terminated116 enrolled
NCT05106335 2023-08-16A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLCJiangsu HengRui Medicine Co., Ltd.Phase 3 Terminated1 enrolled